Synthon (Distribution Rights of Levocetirizine Tablets) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Synthon (Distribution Rights of Levocetirizine Tablets) General Information

Description

Drug distribution and selling rights under the Levocetirizine brand. The asset includes exclusive US rights to sell and distribute levocetirizine tablets, used for the treatment of indoor and outdoor allergies.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Commercial Services
Pharmaceuticals
Acquirer
Primary Office
  • P.O. Box 110487
  • Durham, NC 27709
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Synthon (Distribution Rights of Levocetirizine Tablets) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Synthon (Distribution Rights of Levocetirizine Tablets)‘s full profile, request access.

Request a free trial

Synthon (Distribution Rights of Levocetirizine Tablets) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Synthon (Distribution Rights of Levocetirizine Tablets)‘s full profile, request access.

Request a free trial